Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Anti-amyloid therapy US FDA–approval status
| Name | Synonyms | Company | Target | Therapy type | Approval status |
|---|---|---|---|---|---|
| Aduhelm | Aducanumab, BIIB037 | Biogen, Neurimmune | Aβ aggregates | Immunotherapy (passive) | Accelerated approval |
| Leqembi | Lecanemab-irmb, BAN2401 | BioArctic AB, Biogen, Eisai | Aβ protofibrils | Immunotherapy (passive) | Full approval |
| Donanemab | N3pG-Aβ Monoclonal Antibody, LY3002813 | Eli Lilly & Co | Aβ aggregates | Immunotherapy (passive) | Application for full approval |
